AbbVie today announced that its Phase 3 TEMPO-2 study with

This $ABBV stock news is available only to Bulios Black members.

Upgrade

ABBV

$227.66

AbbVie

+1.29%

What are they talking about

These stocks were most talked about on Bulios today

AAPL

Apple

$291.13

-1.66%

AMZN

Amazon

$238.55

-1.92%

GOOG

Alphabet

$358.16

-0.81%

MSFT

Microsoft

$390.74

-0.18%

NVDA

Nvidia

$205.19

+0.16%

Fair Price Index

List of the largest and most watched stocks from around the world, including their fair prices based on DCF and Relative valuation.

Stock

Result/Price

Fair Price

BABA

Alibaba

Upside

$112.78

$107.39

69.70%

GOOGL

Alphabet

Downside

$359.68

$526.75

86.97%

PLTR

Palantir

Upside

$127.99

$937.63

3.11%

Visa

Downside

$322.34

$035.15

40.52%

XOM

Exxon Mobil

Upside

$147.01

$884.72

04.61%